Cabaletta Bio, Inc. (CABA)

Cabaletta Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.21	163.96	193.24	81.61	122.22	101.43
Short-Term Investments	99.73	-	48.01	24.94	-	7.23
Cash & Short-Term Investments	159.93	163.96	241.25	106.55	122.22	108.66
Cash Growth	-12.61%	-32.04%	126.43%	-12.83%	12.48%	-20.22%
Other Current Assets	4.63	2.71	3.24	2.29	2.32	4.87
Total Current Assets	164.56	166.68	244.49	108.83	124.54	113.54
Net Property, Plant & Equipment	21.59	16.08	7.45	7.57	1.44	0.89
Other Long-Term Assets	3.61	2.29	1.71	0.57	0.36	0.3
Total Assets	189.76	185.05	253.65	116.97	126.34	114.72
Accounts Payable	8.27	4.92	4.55	2.46	2.33	1.24
Accrued Expenses	16.25	12.19	7.89	4.85	6.05	3.94
Current Portion of Leases	21.22	9.98	3.56	2.18	-	-
Total Current Liabilities	45.74	27.09	15.99	9.49	8.38	5.18
Long-Term Leases	4.56	5.63	1.46	2.96	-	-
Total Long-Term Liabilities	4.56	5.63	1.46	2.96	-	-
Total Liabilities	50.29	32.71	17.45	12.45	8.38	5.18
Common Stock	0	0	0	-	-	-
Additional Paid-in Capital	614.48	501.44	469.4	270.13	230.54	175.84
Accumulated Other Comprehensive Income	0.02	-	0.04	-0.05	-	0.01
Retained Earnings	-475.04	-349.1	-233.24	-165.56	-112.59	-66.3
Shareholders' Equity	139.47	152.34	236.2	104.52	117.96	109.54
Total Liabilities & Equity	189.76	185.05	253.65	116.97	126.34	114.72
Total Debt	25.78	15.6	5.02	5.14	0	0
Net Cash (Debt)	134.15	148.36	236.23	101.41	122.22	108.66
Net Cash Growth	-9.58%	-37.20%	132.95%	-17.03%	12.48%	-20.22%
Net Cash Per Share	2.05	3.05	6.34	3.49	4.75	4.70
Book Value	139.47	152.34	236.2	104.52	117.96	109.54
Book Value Per Share	2.13	3.13	6.34	3.60	4.58	4.73
Tangible Book Value	139.47	152.34	236.2	104.52	117.96	109.54
Tangible Book Value Per Share	2.13	3.13	6.34	3.60	4.58	4.73

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q